aim
assess
profil
respiratori
virus
young
children
hospit
acut
lower
respiratori
tract
infect
alri
associ
diseas
sever
defin
need
pediatr
intens
care
unit
picu
admiss
prospect
observ
cohort
studi
tertiarycar
univers
hospit
brazil
children
younger
three
year
attend
pediatr
emerg
room
alri
admit
hospit
none
nasopharyng
aspir
collect
patient
june
st
may
st
first
hour
hospit
nasopharyng
aspir
test
virus
molecular
immunofluoresc
base
assay
simpl
multipl
logbinomi
regress
model
construct
assess
associ
viru
type
need
picu
admiss
age
prematur
presenc
underli
diseas
congenit
heart
diseas
covari
nasopharyng
aspir
posit
least
one
viru
patient
rhinovirus
detect
sampl
preponder
rhinoviru
c
rvc
respiratori
syncyti
viru
detect
human
coronaviru
hcov
sampl
codetect
two
five
virus
found
patient
detect
hcov
alon
adjust
rel
risk
rr
ci
coinfect
rvc
adjust
rr
ci
independ
associ
picu
admiss
detect
hcov
alon
coinfect
rvc
independ
associ
picu
admiss
young
children
hospit
alri
human
coronaviru
alon
coinfect
rhinoviru
c
risk
factor
sever
respiratori
diseas
plo
one
http
doi
acut
lower
respiratori
tract
infect
alri
respons
death
approxim
neonat
infant
annual
respiratori
syncyti
viru
rsv
rhinoviru
rv
frequent
caus
acut
respiratori
infect
children
primari
rsv
infect
may
lead
sever
bronchiol
pneumonia
rv
usual
caus
rhinopharyng
may
also
caus
ill
lower
respiratori
tract
asthma
exacerb
associ
sever
alri
young
children
studi
investig
viral
profil
children
attend
pediatr
emerg
room
er
alri
associ
diseas
sever
find
vari
moreov
role
viral
coinfect
ill
sever
controversi
young
children
present
outpati
clinic
er
japan
acut
respiratori
ill
rsv
rv
parainfluenza
virus
piv
human
metapneumoviru
hmpv
preval
virus
similarli
found
previou
studi
brazil
detect
rsv
alon
codetect
associ
increas
diseas
sever
children
japan
seattl
usa
rv
frequent
viru
detect
children
less
three
year
old
present
er
alri
requir
hospit
admiss
addit
rv
viral
load
codetect
rsv
associ
sever
diseas
studi
children
younger
two
year
old
present
pediatr
er
alri
malaysia
rsv
rv
frequent
detect
virus
although
rsv
associ
histori
wheez
viru
detect
associ
need
hospit
netherland
frequent
virus
detect
children
present
er
outpati
clinic
alri
rsv
rv
human
coronaviru
hcov
rsv
detect
correl
longer
durat
oxygen
therapi
howev
associ
viru
speci
hospit
length
stay
viru
codetect
associ
diseas
outcom
present
studi
comprehens
polymerasechainreact
pcr
panel
primer
probe
use
detect
respiratori
virus
enabl
viru
identif
speci
level
respiratori
sampl
collect
children
younger
three
year
alri
seen
pediatr
er
subsequ
admit
hospit
associ
differ
respiratori
virus
diseas
sever
defin
need
admiss
pediatr
intens
care
unit
picu
assess
prospect
cohort
studi
conduct
tertiarycar
univers
hospit
brazil
studi
approv
research
ethic
committe
clinic
hospit
school
medicin
preto
univers
paulo
tertiarycar
facil
citi
preto
state
sao
paulo
brazil
written
inform
consent
obtain
parentsguardian
protocol
number
hcrp
consecut
children
younger
three
year
attend
pediatr
emerg
room
alri
admit
hospit
june
st
may
st
elig
studi
alri
defin
presenc
cough
tachypnea
respiratori
distress
prolong
expiratori
time
wheez
crackl
auscult
patient
diagnosi
bacteri
pneumonia
indic
clinic
present
chest
xray
find
posit
blood
cultur
exclud
analysi
demograph
clinic
outcom
data
collect
patient
health
record
need
picu
admiss
consid
main
indic
diseas
sever
nasopharyng
aspir
collect
patient
within
first
hour
hospit
previous
describ
split
aliquot
two
aliquot
mix
trizol
invitrogen
thermo
fisher
scientif
usa
dnarna
extract
two
backup
aliquot
mix
viral
transport
medium
consist
minim
essenti
medium
eagl
salt
plu
fetal
bovin
serum
glycerol
antibioticantimycot
solut
gibco
thermo
backup
aliquot
store
analysi
nasopharyng
aspir
routin
screen
rsv
eithera
rapid
chromatograph
immunoassay
rsv
antigen
directigen
ez
rsv
test
becton
dickinson
compani
franklin
lake
nj
usa
indirect
immunofluoresc
assay
directigen
ez
rsv
perform
nasopharyng
aspir
follow
manufactur
protocol
indirect
assay
perform
rsvspecif
monoclon
antibodi
mab
millipor
usa
dilut
phosphatebuff
salin
gibco
thermo
reveal
alexa
trizol
aliquot
sampl
use
dna
rna
extract
total
rna
extract
follow
manufactur
protocol
adapt
http
dnaenrich
fraction
use
dna
purif
use
wizard
genom
dna
purif
kit
promega
madison
wi
usa
per
manufactur
protocol
one
microgram
total
rna
use
revers
transcript
reaction
carri
multiscrib
revers
transcriptas
appli
biosystem
thermo
prime
random
hexam
follow
manufactur
protocol
random
cdna
use
taqman
realtim
pcr
assay
detect
rsva
b
hmpv
b
human
influenza
virus
flu
b
piv
human
betaactin
housekeep
gene
use
intern
control
assay
pcr
assay
perform
use
one
set
primersprob
per
reaction
except
rsv
hmpv
detect
test
duplex
format
human
bocaviru
hbov
human
adenoviru
hadv
detect
qpcr
singl
format
assay
http
hcov
detect
perform
nest
rtpcr
method
use
primer
target
rnadepend
rna
polymerasegen
rhinoviru
rv
detect
wasperform
twostep
pcr
method
http
pcr
reaction
perform
thermocycl
appli
biosystem
thermo
use
publish
primer
probe
sequenc
realtim
pcr
plate
includ
appropri
neg
control
match
everi
step
test
nasopharyng
aspir
neg
control
total
rna
dna
extract
uninfect
hela
cell
ultrapur
water
treat
way
clinic
sampl
analysi
made
use
sa
sasstat
user
guid
version
cari
nc
sa
institut
inc
data
express
median
rang
number
patient
group
accord
need
picu
admiss
continu
variabl
group
compar
mannwhitney
u
test
categor
variabl
fisher
exact
test
simpl
multipl
logbinomi
regress
model
construct
assess
associ
viru
type
need
picu
admiss
rel
risk
rr
confid
interv
ci
obtain
adjust
logbinomi
regress
model
initi
simpl
logbinomi
regress
model
fit
result
crude
rel
risk
subsequ
adjust
multipl
logbinomi
regress
model
consid
age
prematur
presenc
underli
diseas
congenit
heart
diseas
covari
result
adjust
rel
risk
signific
level
consid
analysi
studi
period
nasopharyng
aspir
collect
children
seen
pediatr
emerg
room
alri
thestudi
popul
compris
patient
least
one
respiratori
viru
detect
respiratori
specimen
patient
hospit
twentyf
percent
patient
n
comorbid
common
underli
diseas
neurolog
impair
n
congenit
anomali
n
chronic
lung
diseas
n
fortyseven
patient
admit
picu
receiv
invas
mechan
ventil
median
time
day
rang
day
length
picu
stay
rang
day
median
day
demograph
data
significantli
differ
patient
admit
picu
compar
need
picu
admiss
howev
use
system
antibiot
presenc
underli
diseas
congenit
heart
diseas
frequent
patient
admit
picu
also
longer
hospit
length
stay
tabl
frequent
detect
viru
rv
follow
rsv
hbov
hmpv
hcov
hadv
piv
flu
codetect
found
patient
tabl
result
multipl
logbinomi
regress
analys
show
thatth
detect
hcov
alon
adjust
rel
risk
rr
ci
coinfect
rvc
adjust
rr
ci
independ
associ
picu
admiss
tabl
eight
patient
die
median
age
month
rang
month
six
femal
six
patient
die
comorbid
hydrocephalu
n
pomp
diseas
n
syndrom
n
pulmonari
hypoplasia
n
three
patient
singl
viru
type
detect
respiratori
sampl
rvc
two
patient
rva
one
patient
two
patient
dual
viral
codetect
rvc
rsvb
rvc
hcov
three
patient
tripl
viral
codetect
rsva
flua
hbov
rvc
rsva
hmpva
rvc
hmpva
flub
caus
death
respiratori
insuffici
n
cardiogen
shock
n
septic
shock
n
note
patient
longest
hospit
stay
day
also
longest
durat
mechan
ventil
day
pulmonari
hypoplasia
sever
underli
condit
ultim
die
sepsi
studi
virus
detect
young
children
attend
emerg
room
alri
subsequ
admit
hospit
rv
especi
rvc
frequent
detect
viru
follow
rsv
twenti
percent
patient
admit
picu
comorbid
congenit
heart
diseas
frequent
patient
admit
picu
addit
detect
hcov
alon
coinfect
rvc
independ
associ
picu
admiss
similarli
data
rv
also
commonli
detect
viru
children
younger
year
present
seattl
children
hospit
pediatr
er
symptomat
respiratori
tract
infect
major
lower
respiratori
tract
infect
requir
hospit
rv
also
preval
viru
detect
children
age
two
week
year
admit
hospit
alri
germani
exceed
frequenc
rsv
moreov
rvc
report
frequent
rv
speci
associ
sever
diseas
children
less
year
old
viral
codetect
found
approxim
threequart
studi
popul
rvrsv
frequent
duo
howev
observ
viral
codetect
per
se
risk
factor
picu
admiss
keep
recent
systemat
review
metaanalysi
show
respiratori
viral
coinfect
associ
need
hospit
intens
care
admiss
length
stay
children
addit
number
detect
virus
associ
ill
sever
inde
surprisingli
invers
correl
clinic
sever
score
number
virus
detect
observ
nevertheless
previou
studi
perform
southeast
brazil
show
coinfect
especi
involv
rsv
associ
increas
sever
present
studi
rsv
codetect
virus
associ
increas
diseas
sever
hcov
detect
children
admit
hospit
alri
studi
predomin
type
although
human
coronavirus
frequent
caus
common
cold
may
caus
sever
respiratori
diseas
sever
acut
respiratori
syndrom
observ
onethird
children
hcov
infectionand
patient
withhcov
coinfect
withrvc
admit
picu
furthermor
found
detect
hcov
alon
coinfect
rvc
independ
risk
factor
picu
admissionsimilar
result
hcov
detect
hospit
children
age
year
respiratori
tract
infect
new
york
preval
type
patient
hcovinfectionneed
picu
admiss
addit
presenc
chronic
complex
underli
condit
includ
cardiovascular
genet
respiratori
diseas
associ
increas
diseas
sever
corrobor
data
almost
twothird
children
treat
system
antibiot
high
frequenc
antibiot
use
similar
report
develop
countri
empir
antimicrobi
therapi
driven
unfavor
clinic
condit
face
probabl
bacteri
infect
like
initi
absenc
immedi
laboratori
confirm
viru
detect
present
studi
rapid
diagnost
test
respiratori
viru
availableearli
hospit
admiss
rsv
rapid
antigen
detect
test
therefor
develop
clinic
relev
rapid
test
respiratori
virus
need
shall
help
antimicrobialstewardship
program
sinc
present
studi
done
singl
health
center
rais
concern
epidemiolog
data
may
generaliz
limit
acknowledg
result
obtain
similar
report
europ
north
america
anoth
concern
could
assumpt
diseas
etiolog
base
viru
detect
atonetim
point
howev
practic
diagnost
approach
worldwid
patient
enrol
studi
sign
symptom
alri
requir
hospit
concomitantli
viru
detect
also
note
although
diagnosi
bacteri
pneumonia
indic
clinic
present
chest
xray
find
posit
blood
cultur
exclus
criterion
difficult
discrimin
viral
bacteri
pneumonia
case
neg
bacteri
cultur
clinic
present
chest
radiographi
find
may
overlap
conclus
detect
hcov
alon
coinfect
rvc
independ
associ
picu
admiss
young
children
hospit
alrirapid
reliabl
diagnost
test
respiratori
virus
associ
diseas
sever
wide
avail
improv
patient
manag
optim
healthcar
resourc
support
inform
